MIGLITOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Miglitol, and what generic alternatives are available?
Miglitol is a drug marketed by Westminster Pharms and is included in one NDA.
The generic ingredient in MIGLITOL is miglitol. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the miglitol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Miglitol
A generic version of MIGLITOL was approved as miglitol by WESTMINSTER PHARMS on February 24th, 2015.
Summary for MIGLITOL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 88 |
Clinical Trials: | 13 |
Patent Applications: | 4,554 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for MIGLITOL |
DailyMed Link: | MIGLITOL at DailyMed |
Recent Clinical Trials for MIGLITOL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Zambia | Phase 3 |
University Teaching Hospital, Lusaka, Zambia | Phase 3 |
Drug Safety and Effectiveness Network, Canada |
Pharmacology for MIGLITOL
Drug Class | alpha-Glucosidase Inhibitor |
Mechanism of Action | alpha Glucosidase Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for MIGLITOL
US Patents and Regulatory Information for MIGLITOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Westminster Pharms | MIGLITOL | miglitol | TABLET;ORAL | 203965-001 | Feb 24, 2015 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Westminster Pharms | MIGLITOL | miglitol | TABLET;ORAL | 203965-002 | Feb 24, 2015 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Westminster Pharms | MIGLITOL | miglitol | TABLET;ORAL | 203965-003 | Feb 24, 2015 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |